Geneoscopy

Geneoscopy is a commercial-stage molecular diagnostics company headquartered in St. Louis, Missouri, focused on gastrointestinal health. Its platform analyzes stool-derived eukaryotic RNA (seRNA) biomarkers, a proprietary approach the company applies to colorectal cancer screening, inflammatory bowel disease and other gastrointestinal conditions. Its lead product, ColoSense, is a noninvasive multi-target stool RNA (mt-sRNA) colorectal cancer screening test approved by the FDA in May 2024 for adults aged 45 and older at average risk; it evaluates eight colorectal neoplasia-associated RNA markers together with occult hemoglobin, and has since been added to the American Cancer Society and NCCN colorectal cancer screening guidelines. Geneoscopy operates a CLIA-certified (26D2253457) and CAP-accredited clinical laboratory with permits in New York, California, Maryland, Pennsylvania, Rhode Island and the District of Columbia, and partners with biopharma and research organizations on stool-biomarker diagnostics and prognostics. Geneoscopy is a diagnostics and clinical-laboratory company; as of this profile it publishes no public developer API, SDK, developer portal, or machine-readable API contract.

Geneoscopy is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Diagnostics, Molecular Diagnostics, and Colorectal Cancer.

Geneoscopy’s developer surface includes engineering blog and 21 more developer resources.

🌐 Visit website 📡 Source on GitHub

13.7/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyHealthcareDiagnosticsMolecular DiagnosticsColorectal CancerCancer ScreeningRNAClinical LaboratoryLife SciencesGastroenterology

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 13.7/100 · emerging

Contract Quality 0.0 / 21

Developer Ergonomics 0.4 / 17

Commercial Clarity 4.9 / 17

Operational Transparency 0.0 / 11

Governance 0.0 / 10

Discoverability 4.9 / 9

Regulatory Posture 3.6 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/geneoscopy: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Access & Security 2

Authentication, authorization, and security posture

Compliance

Compliance

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact

Contact

Commercial 3

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

PrivacyNotice

PrivacyNotice

Company 8

The organization behind the API

Website

About

Partners

Careers

Blog

BlogFeeds

LinkedIn

Twitter

Twitter

Scroll for all 8

Other 7

Properties that don't map to a standard resource type

Leadership

Product

Product

Products

Research

Regulatory

Marketplace

Scroll for all 7

Source (apis.yml)

aid: geneoscopy
name: Geneoscopy
description: Geneoscopy is a commercial-stage molecular diagnostics company headquartered in St. Louis, Missouri, focused
  on gastrointestinal health. Its platform analyzes stool-derived eukaryotic RNA (seRNA) biomarkers, a proprietary approach
  the company applies to colorectal cancer screening, inflammatory bowel disease and other gastrointestinal conditions. Its
  lead product, ColoSense, is a noninvasive multi-target stool RNA (mt-sRNA) colorectal cancer screening test approved by
  the FDA in May 2024 for adults aged 45 and older at average risk; it evaluates eight colorectal neoplasia-associated RNA
  markers together with occult hemoglobin, and has since been added to the American Cancer Society and NCCN colorectal cancer
  screening guidelines. Geneoscopy operates a CLIA-certified (26D2253457) and CAP-accredited clinical laboratory with permits
  in New York, California, Maryland, Pennsylvania, Rhode Island and the District of Columbia, and partners with biopharma
  and research organizations on stool-biomarker diagnostics and prognostics. Geneoscopy is a diagnostics and clinical-laboratory
  company; as of this profile it publishes no public developer API, SDK, developer portal, or machine-readable API contract.
url: https://raw.githubusercontent.com/api-evangelist/geneoscopy/refs/heads/main/apis.yml
image: https://www.geneoscopy.com/wp-content/uploads/logo.png
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.20'
created: '2026-08-04'
modified: '2026-08-04'
tags:
- Company
- Healthcare
- Diagnostics
- Molecular Diagnostics
- Colorectal Cancer
- Cancer Screening
- RNA
- Clinical Laboratory
- Life Sciences
- Gastroenterology
apis: []
x-enrichment:
  date: '2026-08-04'
  status: minimal
  artifacts_added: 3
  pass: local-v1
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.geneoscopy.com/
- type: About
  url: https://www.geneoscopy.com/about-us/
- type: Leadership
  url: https://www.geneoscopy.com/about-us/our-leadership/
- type: Product
  name: ColoSense
  url: https://www.geneoscopy.com/colosense/
- type: Product
  name: ColoSense patient site
  url: https://colosense.com/
- type: Products
  url: https://www.geneoscopy.com/gastrointestinal-health/
- type: Research
  url: https://www.geneoscopy.com/gastrointestinal-health/clinical-evidence/
- type: Compliance
  name: Our Lab and Our Credentials (CLIA 26D2253457, CAP, state permits)
  url: https://www.geneoscopy.com/about-us/our-lab-and-our-credentials/
- type: Partners
  url: https://www.geneoscopy.com/partnerships/
- type: Careers
  url: https://www.geneoscopy.com/careers/
- type: Contact
  url: https://www.geneoscopy.com/about-us/contact/
- type: Blog
  name: Newsroom
  url: https://www.geneoscopy.com/press-releases/
- type: BlogFeeds
  url: https://www.geneoscopy.com/feed/
- type: TermsOfService
  url: https://www.geneoscopy.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.geneoscopy.com/privacy-policy/
- type: PrivacyNotice
  name: HIPAA Notice of Privacy Practices
  url: https://www.geneoscopy.com/notice-of-privacy/
- type: Regulatory
  name: ColoSense Instructions for Use
  url: https://www.geneoscopy.com/colosense/ifu/
- type: LinkedIn
  url: https://www.linkedin.com/company/geneoscopy
- type: Twitter
  url: https://twitter.com/GeneoscopyCo
- type: Marketplace
  name: Geneoscopy stock on Forge Global (third party)
  url: https://forgeglobal.com/geneoscopy_stock/
- type: DomainSecurity
  url: security/geneoscopy-domain-security.yml
- type: LLMsTxt
  url: llms/geneoscopy-llms.txt